Expertise vs. evidence in assessment of breast biopsies
Apr 01, 2015 02:00PM ● Published by Cate Reynolds
The JAMA article said, “Breast biopsies are performed in 1.6 million women in the United States each year and yield results ranging from benign to atypical hyperplasia to carcinoma in situ to invasive cancer, each with specific implications for subsequent management.”
In other words, the biopsy determines treatment, so it darn well better be accurate and exact. The study found, however, that participating pathologists were only able to “correctly” diagnose breast biopsies about 75 percent of the time.
The general reaction to the report is heralding it as a call to action to improve training and accuracy. And, we’d think, to increase the use of second opinions in those biopsies which fall into the gray-ish areas of diagnosis.
Click here to sign up to our new Health Beat E-Newsletter